Neurofilament (ABT456) mouse mAb (Ready to Use)

  • Catalog No.:YM6897R
  • Applications:IHC
  • Reactivity:Human;Mouse;Rat;
    • Target:
    • NF-L
    • Fields:
    • >>Amyotrophic lateral sclerosis;>>Pathways of neurodegeneration - multiple diseases
    • Gene Name:
    • NEFL NF68 NFL
    • Protein Name:
    • Neurofilament
    • Human Gene Id:
    • 4747
    • Human Swiss Prot No:
    • P07196
    • Immunogen:
    • Synthesized peptide derived from human Neurofilament AA range: 400-543
    • Specificity:
    • The antibody can specifically recognize human Neurofilament protein, especilaly NF-L protein.
    • Formulation:
    • The prediluted ready-to-use antibody is diluted in phosphate buffer saline containing stabilizing protein and 0.05% Proclin 300
    • Source:
    • Mouse, Monoclonal/IgG1, kappa
    • Dilution:
    • Ready to use for IHC
    • Purification:
    • The antibody was affinity-purified from ascites by affinity-chromatography using specific immunogen.
    • Storage Stability:
    • 2°C to 8°C/1 year
    • Other Name:
    • Neurofilament light polypeptide (NF-L;68 kDa neurofilament protein;Neurofilament triplet L protein)
    • Background:
    • Neurofilaments are type IV intermediate filament heteropolymers composed of light, medium, and heavy chains. Neurofilaments comprise the axoskeleton and they functionally maintain the neuronal caliber. They may also play a role in intracellular transport to axons and dendrites. This gene encodes the light chain neurofilament protein. Mutations in this gene cause Charcot-Marie-Tooth disease types 1F (CMT1F) and 2E (CMT2E), disorders of the peripheral nervous system that are characterized by distinct neuropathies. A pseudogene has been identified on chromosome Y. [provided by RefSeq, Oct 2008],
    • Function:
    • caution:The sequence shown here is derived from an Ensembl automatic analysis pipeline and should be considered as preliminary data.,disease:Defects in NEFL are the cause of Charcot-Marie-Tooth disease type 1F (CMT1F) [MIM:607734]. CMT1F is a form of Charcot-Marie-Tooth disease, the most common inherited disorder of the peripheral nervous system. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathy or CMT1, and primary peripheral axonal neuropathy or CMT2. Neuropathies of the CMT1 group are characterized by severely reduced nerve conduction velocities (less than 38 m/sec), segmental demyelination and remyelination with onion bulb formations on nerve biopsy, slowly progressive distal muscle atrophy and weakness, absent deep tendon reflexes, and hollow feet. CMT1F is charac
    • Subcellular Location:
    • Cytoplasmic
    • Expression:
    • Cytoplasmic